logo-loader
NASDAQ:INCY

Incyte Corporation

Receive alerts
Market:
NASDAQ
Price
57.34 USD
Day Change
-1.76%
Market Cap:
$12.87 b
52 weeks high
76.03
52 weeks low
50.27

In brief

Incyte Corporation is a biopharmaceutical company, which is focused on the discovery, development and commercialization of therapeutics. The company also conducts commercial and clinical development operations from its European headquarters in Morges, Switzerland, and Japanese office in Tokyo and Canadian headquarters in Montreal. It operates in two therapeutic areas, One therapeutic area is Hematology/Oncology, which is comprised of Myeloproliferative Neoplasms and Graft-Versus-Host Disease, as well as solid tumors and hematologic malignancies.